Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Funding of R8.7million for skills development in manufacturing and teacher training signed over to UFS

2017-06-19

Description: MerSETA funding Tags: MerSETA funding

The MerSETA (Skills and Training Authority for Manufacturing, Engineering and Related Industries) signed a Memorandum of Agreement (MOA) with the University of the Free State (UFS) for a grant of approximately R8.7million on 14 June 2017, which will be disbursed over a three-year period.

UFS seeks to bridge the skills gap
As a response to the need for skills development in the manufacturing, engineering and related industries sector, and as an institution of higher learning optimally placed to serve the population of central South Africa, the UFS proposed a partnership with MerSETA to address challenges in the sector. The interventions that MerSETA will fund include training for 600 vocational teachers, research and development of a green building mechanical index, in-service training for 60 IT Teachers and microbotics classes for 100 students.

The CEO of MerSETA, and UFS alumnus Dr Raymond Patel, said the funding for rare skills such as in science and engineering are of great importance for the country. The ability to train teachers and to upskill them will yield great results for the economy as a whole. Rector and Vice-Chancellor Prof Francis Petersen said the UFS partnership with SETAs and with MerSETA in particular should be mutually beneficial, and went a long way in integrating first-generation university students to be better-prepared for university studies.

Collaboration and support key within university departments
The delegates visited the Departments of Education and Engineering Sciences on the Bloemfontein Campus, where they met project leaders Louis Lagrange from the Faculty of Natural and Agricultural Sciences, Dr Nixon Teis, Faculty of Education, and Pat Lamusse, Institutional Advancement. Present at the signing ceremony were members of the Rectorate, the Acting Dean of the faculty of Education, Prof Loyiso Jita, and Dean of the Faculty of Natural and Agricultural Sciences, Prof Danie Vermeulen, as well as researchers who will be working on the green building mechanical use index and other MerSETA representatives.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept